esme 28 tablet
mylan pharmaceuticals ulc - levonorgestrel; ethinyl estradiol - tablet - 100mcg; 20mcg - levonorgestrel 100mcg; ethinyl estradiol 20mcg - contraceptives
lutera 21 tablet
cobalt pharmaceuticals company - levonorgestrel; ethinyl estradiol - tablet - 100.0mcg; 20.0mcg - levonorgestrel 100.0mcg; ethinyl estradiol 20.0mcg - contraceptives
lutera 28 tablet
cobalt pharmaceuticals company - levonorgestrel; ethinyl estradiol - tablet - 100.0mcg; 20.0mcg - levonorgestrel 100.0mcg; ethinyl estradiol 20.0mcg - contraceptives
laylaa 21 tablet
lupin pharma canada limited - levonorgestrel; ethinyl estradiol - tablet - 0.1mg; 0.02mg - levonorgestrel 0.1mg; ethinyl estradiol 0.02mg - contraceptives
laylaa 28 tablet
lupin pharma canada limited - levonorgestrel; ethinyl estradiol - tablet - 0.1mg; 0.02mg - levonorgestrel 0.1mg; ethinyl estradiol 0.02mg - contraceptives
gildess fe 1.5/30 norethindrone acetate ethinyl estradiol and ferrous fumarate
qualitest pharmaceuticals - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s) - norethindrone acetate 1.5 mg
gildess fe 1/20 norethindrone acetate ethinyl estradiol and ferrous fumarate
qualitest pharmaceuticals - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s) - norethindrone acetate 1 mg
gildess 1/20 norethindrone acetate and ethinyl estradiol tablet film coated
qualitest pharmaceuticals - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s) - norethindrone acetate 1 mg
blisovi fe 1.5/30- norethindrone acetate and ethinyl estradiol kit
lupin pharmaceuticals, inc. - ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u), norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s) - ethinyl estradiol 0.03 mg - blisovi fe 1.5/30 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. adapted from ra hatcher et al, reference 7. oral contraceptives should not be used in women who currently have the following conditions: - thrombophlebitis or thromboembolic disorders - a past history of deep vein thrombophlebitis or thromboembolic disorders - cerebral vascular or coronary artery disease - known or suspected carcinoma of the breast - carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia - undiagnosed abnormal genital bleeding - cholestatic jaundice of
gildess 1.5/30 norethindrone acetate and ethinyl estradiol tablet film coated
qualitest pharmaceuticals - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s) - norethindrone acetate 1.5 mg